EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic

Marisol Aguirre iD, Manuela Escobar, Sebastián Forero Amézquita iD, David Cubillos iD, Camilo Rincón, Paula Vanegas, María Paula Tarazona, Sofía Atuesta Escobar, Juan Camilo Blanco, Luis Gustavo Celis iD

Genes · 2023

DOI: 10.3390/genes14091697 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, 2023. Verfasst von Marisol Aguirre und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Fundación Valle del Lili, Cali 760026, Colombia. Hauptthemen laut MEDLINE: Carcinoma, Sarcoma. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de La Sabana.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factors Oct4, Sox2, Klf4, and c-Myc enable the reprogramming of somatic cells into induced pluripotent cells. Reprogramming generates newly differentiated cells for potential therapies in cancer, neurodegenerative diseases, and rejuvenation processes. In cancer therapies, these transcription factors lead to a reduction in the size and aggressiveness of certain tumors, such as sarcomas, and in neurodegenerative diseases, they enable the production of dopaminergic cells in Parkinson’s disease, the replacement of affected neuronal cells in olivopontocerebellar atrophy, and the regeneration of the optic nerve. However, there are limitations, such as an increased risk of cancer development when using Klf4 and c-Myc and the occurrence of abnormal dyskinesias in the medium term, possibly generated by the uncontrolled growth of differentiated dopaminergic cells and the impairment of the survival of the new cells. Therefore, the Yamanaka transcription factors have shown therapeutic potential through cell reprogramming for some carcinomas, neurodegenerative diseases, and rejuvenation. However, the limitations found in the studies require further investigation before the use of these transcription factors in humans.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarcinomaSarcomaHumansCell DifferentiationLaboratoriesOctamer Transcription Factor-3Kruppel-Like Factor 4SOXB1 Transcription FactorsProto-Oncogene Proteins c-myc

Stichwörter der Autor:innen

Klf4Oct4Sox2c-Myccancercell- and tissue-based therapyinduced pluripotent stem cellsneurodegenerative diseasesrejuvenation

Substanzen

Octamer Transcription Factor-3POU5F1 protein, humanKruppel-Like Factor 4SOX2 protein, humanSOXB1 Transcription FactorsProto-Oncogene Proteins c-myc

Autor:innen und Institutionen

  • Department of Genetics, Fundación Valle del Lili, Cali 760026, Colombia.
  • Faculty of Medicine, Universidad Icesi, Cali 760031, Colombia.
  • Faculty of Medicine, Universidad de La Sabana, Km 7, Autopista Norte de Bogotá, Chía 250001, Colombia.

ORCID-Profile: Marisol Aguirre, Sebastián Forero Amézquita, David Cubillos, Luis Gustavo Celis

Förderung

  • Universidad de La Sabana

Zitieren

APA

Aguirre, M., Escobar, M., Forero Amézquita, S., Cubillos, D., Rincón, C., Vanegas, P., Tarazona, M. P., Atuesta Escobar, S., Blanco, J. C., & Celis, L. G. (2023). Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic. Genes. https://doi.org/10.3390/genes14091697

Vancouver

Aguirre M, Escobar M, Forero Amézquita S, Cubillos D, Rincón C, Vanegas P, et al. Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic. Genes. 2023. doi:10.3390/genes14091697

BibTeX
@article{Aguirre2023,
  author = {Aguirre, Marisol and Escobar, Manuela and Forero Amézquita, Sebastián and Cubillos, David and Rincón, Camilo and Vanegas, Paula and Tarazona, María Paula and Atuesta Escobar, Sofía and Blanco, Juan Camilo and Celis, Luis Gustavo},
  title = {Application of the Yamanaka Transcription Factors Oct4, Sox2, Klf4, and c-Myc from the Laboratory to the Clinic},
  journal = {Genes},
  year = {2023},
  doi = {10.3390/genes14091697}
}
Kostenlos starten →